Investors & Media

Lonnel Coats has served as a member of our Board of Directors since February 2016 and is the Chair of the Nominating and Corporate Governance Committee. Since July 2014, Mr. Coats has served as Chief Executive Officer and a member of the Board of Directors of Lexicon Pharmaceuticals, Inc., a biopharmaceutical company pioneering medicines for a range of diseases including neuropathic pain, heart failure, diabetes and metabolism. Prior to joining Lexicon, from 1996 to June 2014, Mr. Coats served in a series of leadership positions at Eisai, Inc. and Eisai Corporation of North America, both of which are U.S. subsidiaries of Tokyo-based Eisai Co., Ltd., including as Chief Executive Officer of Eisai, Inc. from 2010 to June 2014 and as President and Chief Operating Officer of Eisai, Inc. from 2004 to 2010. Mr. Coats also previously held a variety of sales and management positions at Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson, from 1988 to 1996. Mr. Coats currently serves as a member of the Audit Committee of the Board of Directors of Verve Therapeutics, Inc. Mr. Coats received a B.S. in public administration from Oakland University.